Eli Lilly will move forward

Investor's Business Daily

Eli Lilly will move forward with Amyvid, an imaging chemical that helps screen for Alzheimer's disease by highlighting brain plaque in medical imaging scans — even though Medicare officials don't plan to provide coverage, AP said. Lilly (LLY) shares rose 1.1% to 51.13.

View Comments (0)